315 results on '"Schumacher, Karl"'
Search Results
2. Quantitative susceptibility mapping for detection of kidney stones, hemorrhage differentiation and cyst classification in ADPKD
3. SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations
4. The Influence of Culture Media on Embryonic Renal Collecting Duct Cell Differentiation
5. Supplementary Data from Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice
6. SYST-06 INTRACRANIAL ACTIVITY OF TEPOTINIB IN PATIENTS WITH MET EXON 14 (METEX14) SKIPPING NSCLC ENROLLED IN VISION
7. Mikroreaktortechnik für Tissue Engineering
8. A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy
9. Abstract 1105: MET or SHP2 inhibition enhances targeted therapies and delays the emergence of resistance in oncogene-driven NSCLC
10. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
11. Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice
12. INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance
13. First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study
14. INNV-21. COMPLETE RESPONSE TO ADJUVANT TEPOTINIB IN A PATIENT WITH NEWLY DIAGNOSED DISSEMINATED GLIOBLASTOMA (GBM) HARBORING MET AMPLIFICATION
15. CNC-gesteuerte Mehrspindel-Drehautomaten
16. Hydrodynamic spinning of hydrogel fibers
17. TRLS-03. Intracranial activity of tepotinib in patients with MET exon 14 (METex14) skipping NSCLC enrolled in VISION
18. Cell immobilization in gelatin–hydroxyphenylpropionic acid hydrogel fibers
19. Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study
20. Tepotinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) with MET amplification (METamp).
21. Intracranial activity of tepotinib in patients (pts) with MET exon 14 (METex14) skipping NSCLC enrolled in VISION.
22. PERSPECTIVE: Tepotinib + cetuximab in patients (pts) with RAS/BRAF wild-type left-sided metastatic colorectal cancer (mCRC) and acquired resistance to anti-EGFR antibody therapy due to MET amplification (METamp).
23. INSIGHT 2: a phase II study of tepotinib plus osimertinib in -amplified NSCLC and first-line osimertinib resistance.
24. Activity of tepotinib in hepatocellular carcinoma (HCC) with high-level MET amplification (METamp): Preclinical and clinical evidence.
25. Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe disease
26. Temporal-spatial co-localisation of tissue transglutaminase (Tgase2) and matrix metalloproteinase-9 (MMP-9) with SBA-positive micro-fibres in the embryonic kidney cortex
27. Differential regulation of renin and Cox-2 expression in the renal cortex of C57Bl/6 mice
28. Detection of glycosylated sites in embryonic rabbit kidney by lectin chemistry
29. Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake
30. Transhepatic topical dissolution of gallbladder stones with MTBE and EDTA: Results, side effects, and correlation with CT imaging
31. Urea Restrains Aldosterone-Induced Development of Peanut Agglutinin–Binding on Embryonic Renal Collecting Duct Epithelia
32. THE SBA-POSITIVE FIBER SYSTEM AT THE CD AMPULLA TIP REPRESENTS A GROWTH CUE FOR KIDNEY DEVELOPMENT
33. SBA-Positive Fibers between the CD Ampulla, Mesenchyme, and Renal Capsule
34. Low Tonicity Mediates a Downregulation of Cyclooxygenase-1 Expression by Furosemide in the Rat Renal Papilla
35. Role of Renocortical Cyclooxygenase-2 for Renal Vascular Resistance and Macula Densa Control of Renin Secretion
36. Eine neue Germanen-Darstellung im Römisch-Germanischen Zentralmuseum zu Mainz
37. Additional file 1: of A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy
38. The Romanesque monastery church Maria Laach, their natural building blocks and their geological origin
39. Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor–Positive Advanced Breast Cancer
40. Advanced technique for long term culture of epithelia in a continuous luminal–basal medium gradient
41. Computed tomography after ESWL of gallbladder calculi
42. Blending in: UV-curable polymers combine hot-melt coating technology with acrylic high-performance chemistry. (Research & Technology Hot Melt/Acrylics)
43. Λίθος Λάρτιος
44. Verschleppte griechische Inschriften
45. Eine griechische Inschrift des Cyriacus
46. Nochmals: Hilfstatsachen in der Relation: Eine Erwiderung
47. Barbarische und griechische Spiegel
48. PS01.60: Ph Ib/II, Trial of INC280 ± Erlotinib vs Platinum + Pemetrexed in Adult pts with EGFR-Mutated, cMET amplified, EGFR TKI Resistant, Advanced NSCLC: Topic: Medical Oncology
49. Gerda Bernhard, Das nördliche Rheinhessen
50. PS01.60: Ph Ib/II, Trial of INC280 ± Erlotinib vs Platinum + Pemetrexed in Adult pts with EGFR-Mutated, cMET amplified, EGFR TKI Resistant, Advanced NSCLC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.